JP2005528351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528351A5 JP2005528351A5 JP2003574110A JP2003574110A JP2005528351A5 JP 2005528351 A5 JP2005528351 A5 JP 2005528351A5 JP 2003574110 A JP2003574110 A JP 2003574110A JP 2003574110 A JP2003574110 A JP 2003574110A JP 2005528351 A5 JP2005528351 A5 JP 2005528351A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- mixtures
- chelating agent
- activated protein
- diluent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36336402P | 2002-03-08 | 2002-03-08 | |
| PCT/US2003/005046 WO2003075834A2 (en) | 2002-03-08 | 2003-02-27 | Activated protein c formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528351A JP2005528351A (ja) | 2005-09-22 |
| JP2005528351A5 true JP2005528351A5 (cg-RX-API-DMAC7.html) | 2006-04-13 |
Family
ID=27805279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003574110A Pending JP2005528351A (ja) | 2002-03-08 | 2003-02-27 | 活性化プロテインc製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050143283A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1485121A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005528351A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003213146A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2475738A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003075834A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2409349C2 (ru) * | 2006-04-14 | 2011-01-20 | Маннкайнд Корпорейшн | Фармацевтические композиции, содержащие глюкагонподобный пептид(glp-1) |
| US20110171200A1 (en) * | 2008-01-15 | 2011-07-14 | Walley Keith R | Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| WO2012068519A2 (en) | 2010-11-19 | 2012-05-24 | Sirius Genomics Inc. | Markers associated with response to activated protein c administration, and uses thereof |
| US9757433B2 (en) * | 2013-01-14 | 2017-09-12 | Apeiron Biologicals AG | Modified ACE2 polypeptides |
| US11058750B2 (en) * | 2015-12-03 | 2021-07-13 | Mor Research Applications Ltd. | Compositions and methods for treatment of ocular diseases |
| DK3463308T4 (da) * | 2016-06-01 | 2026-02-09 | Servier Ip Uk Ltd | Formuleringer af polyalkylenoxid-asparaginase og fremgangsmåder til fremstilling og anvendelse deraf |
| WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
| US4849403A (en) * | 1985-05-29 | 1989-07-18 | Pentapharm Ag | Protein C activator, methods of preparation and use thereof |
| US5516650A (en) * | 1985-06-27 | 1996-05-14 | Zymogenetics, Inc. | Production of activated protein C |
| DE3607559A1 (de) * | 1986-03-07 | 1987-09-10 | Boehringer Mannheim Gmbh | Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet |
| AT399095B (de) * | 1986-03-27 | 1995-03-27 | Vukovich Thomas Dr | Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens |
| US5175087A (en) * | 1987-07-06 | 1992-12-29 | Biopool International, Inc. | Method of performing tissue plasminogen activator assay |
| US4877608A (en) * | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
| US4992373A (en) * | 1987-12-04 | 1991-02-12 | Eli Lilly And Company | Vectors and compounds for direct expression of activated human protein C |
| JP2739050B2 (ja) * | 1988-01-28 | 1998-04-08 | ヘキスト薬品工業株式会社 | 抗血液凝固剤 |
| US4981952A (en) * | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
| US5093117A (en) * | 1989-01-24 | 1992-03-03 | Baxter International Inc. | Compositions and method for the treatment or prophylaxis of sepsis or septic shock |
| AT402262B (de) * | 1991-06-20 | 1997-03-25 | Immuno Ag | Arzneimittel enthaltend aktiviertes protein c |
| US5413732A (en) * | 1991-08-19 | 1995-05-09 | Abaxis, Inc. | Reagent compositions for analytical testing |
| MY110664A (en) * | 1992-05-21 | 1999-01-30 | Lilly Co Eli | Protein c derivatives |
| DE4234295A1 (de) * | 1992-10-12 | 1994-04-14 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5395923A (en) * | 1993-02-23 | 1995-03-07 | Haemacure-Biotech, Inc. | Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out" |
| JP3043558B2 (ja) * | 1993-10-29 | 2000-05-22 | 財団法人化学及血清療法研究所 | ヒト活性化プロテインc調製物及びその製法 |
| JP2886061B2 (ja) * | 1993-10-29 | 1999-04-26 | 財団法人化学及血清療法研究所 | プロテインcもしくは活性化プロテインcの安定化方法及び安定化組成物 |
| ZA983497B (en) * | 1997-04-28 | 1999-10-25 | Lilly Co Eli | Activated protein c formulations. |
| US6630137B1 (en) * | 1997-04-28 | 2003-10-07 | Eli Lilly And Company | Activated protein C formulations |
| AT409334B (de) * | 1997-09-19 | 2002-07-25 | Immuno Ag | Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren |
| HUP0001237A3 (en) * | 1997-10-20 | 2002-01-28 | Lilly Co Eli | Methods for treating vascular disorders |
| EP1417055A4 (en) * | 2001-07-19 | 2007-09-26 | Dmi Biosciences Inc | USE OF COPPER CHELATORS TO PREVENT THE INACTIVATION OF PROTEIN C |
-
2003
- 2003-02-27 CA CA002475738A patent/CA2475738A1/en not_active Abandoned
- 2003-02-27 US US10/506,301 patent/US20050143283A1/en not_active Abandoned
- 2003-02-27 AU AU2003213146A patent/AU2003213146A1/en not_active Abandoned
- 2003-02-27 JP JP2003574110A patent/JP2005528351A/ja active Pending
- 2003-02-27 WO PCT/US2003/005046 patent/WO2003075834A2/en not_active Ceased
- 2003-02-27 EP EP03709192A patent/EP1485121A4/en not_active Withdrawn